EU Cosmetic Products Regulation
The EU regulation governing cosmetic products placed on the EU market. It requires a designated Responsible Person, a Product Information File with a Cosmetic Product Safety Report, notification via the CPNP portal, GMP compliance (aligned to ISO 22716), ingredient restrictions, and cosmetovigilance for undesirable effects.
Cosmetic products on the EU market — safety assessment, GMP, ingredient control, labelling, and post-market cosmetovigilance.
- 01Designate a Responsible Person and maintain the Product Information File
- 02Hold a Cosmetic Product Safety Report by a qualified assessor
- 03Comply with GMP (ISO 22716) and notify products via CPNP
- 04Respect ingredient Annexes and operate cosmetovigilance
Applying since July 2013 (replacing Directive 76/768/EEC); amended regularly via its Annexes as substance assessments evolve.
Regulation (EC) No 1223/2009: frequently asked questions
Quick answers to common questions about Regulation (EC) No 1223/2009.
What is Regulation (EC) No 1223/2009?
Regulation (EC) No 1223/2009 — EU Cosmetic Products Regulation — is a regulation issued by the European Commission — EudraLex (European Union). The EU regulation governing cosmetic products placed on the EU market. It requires a designated Responsible Person, a Product Information File with a Cosmetic Product Safety Report, notification via the CPNP portal, GMP compliance (aligned to ISO 22716), ingredient restrictions, and cosmetovigilance for undesirable effects.
Who does Regulation (EC) No 1223/2009 apply to?
Cosmetic products on the EU market — safety assessment, GMP, ingredient control, labelling, and post-market cosmetovigilance.
What are the key requirements of Regulation (EC) No 1223/2009?
EC Regulation (EC) No 1223/2009 requires, among other things: Designate a Responsible Person and maintain the Product Information File; Hold a Cosmetic Product Safety Report by a qualified assessor; Comply with GMP (ISO 22716) and notify products via CPNP; Respect ingredient Annexes and operate cosmetovigilance.
When was Regulation (EC) No 1223/2009 last updated?
The current version of Regulation (EC) No 1223/2009 dates from July 2013. Applying since July 2013 (replacing Directive 76/768/EEC); amended regularly via its Annexes as substance assessments evolve.
Live openFDA recalls SPEQ maps to this standard’s topics — a SPEQ interpretation, not an FDA classification.
Recall domain is a SPEQ mapping of this standard’s topics, not an FDA classification.
Track the standards that move
When Regulation (EC) No 1223/2009 — or any GxP requirement — is revised, recalled against, or clarified by new guidance, the Weekly GxP Briefing surfaces it. Free, one email a week.